文献速递临床试验与 GCP

黑色素瘤脑转移局部治疗后全脑放疗(WBRT):统计分析计划

Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan.
PubMed 文献 · Trials · 2019-08-05

WBRTMel试验是一项跨国、开放标签、III期随机对照试验,比较黑色素瘤脑转移(1至3个)局部治疗(手术和/或立体定向照射)后行全脑放疗与观察的效应。主要终点为颅内远处控制,次要终点包括神经认知功能、生活质量、体能状态、总生存等。本文在数据库锁定和分析开始前发布预先制定的统计分析计划(SAP),以规范主要分析、亚组和敏感性分析,避免分析偏倚。

要点

  • WBRTMel试验比较黑色素瘤脑转移局部治疗后全脑放疗与观察的疗效。
  • 主要终点为颅内远处控制,次要终点包括神经认知功能、生活质量和总生存。
  • 统计分析计划在数据库锁定前制定并发布,以避免分析偏倚。

核心结论

  • 已为WBRTMel试验制定统计分析计划,将遵循该计划以确保高质量的内部有效性标准并最小化分析偏倚。

研究设计与样本

  • WBRTMel试验为跨国、开放标签、III期随机对照试验,比较黑色素瘤脑转移(1至3个)局部治疗(手术和/或立体定向照射)后全脑放疗与观察。
  • 统计分析计划在招募结束后、患者随访完成前获批,概述了计划的主要分析以及关于临床和生活质量结局的一系列亚组和敏感性分析。
  • 卫生经济学结局未纳入本计划,将另行分析。

主要发现

  • 主要终点为评估在局部治疗基础上增加全脑放疗对颅内远处控制的影响。
  • 次要终点包括神经认知功能、生活质量、体能状态、总生存、颅内原因死亡、黑色素瘤死亡和成本效果。
  • 统计分析计划描述了基本分析原则、处理常见数据分析问题的方法以及分析疗效和安全性结局的具体统计程序。

关键数值与推荐

  • 统计分析计划在数据库锁定和分析开始前发布,最终数据分析将遵循该计划以避免因知晓数据而产生的分析偏倚。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The WBRTMel trial is a multinational, open-label, phase III randomised controlled trial comparing whole brain radiotherapy (WBRT) to observation following local treatment of one to three melanoma brain metastases with surgery and/or stereotactic irradiation. The primary trial endpoint was to determine the effect of adding WBRT to local treatment on distant intracranial control, and the secondary endpoints were neurocognitive function, quality of life (QoL), performance status, overall survival, death from intracranial causes, death from melanoma and cost-effectiveness. OBJECTIVE: The objective of this update is to outline and publish the pre-determined statistical analysis plan (SAP) before the database lock and the start of analysis. METHODS: The SAP describes basic analysis principles, methods for dealing with a range of commonly encountered data analysis issues and the specific statistical procedures for analysing efficacy and safety outcomes. The SAP was approved after closure of recruitment and before completion of patient follow-up. It outlines the planned primary analyses and a range of subgroup and sensitivity analyses regarding the clinical and QoL outcomes. Health economic outcomes are not included in this plan but will be analysed separately. The SAP will be adhered to for the final data analysis of this trial to avoid analysis bias arising from knowledge of the data. RESULTS: The resulting SAP is consistent with best practice and will allow open and transparent reporting. CONCLUSION: We have developed a SAP for the WBRTMel trial which will be followed to ensure high-quality standards of internal validity to minimise analysis bias. TRIAL REGISTRATION: ANZ Clinical Trials Registry, ACTRN12607000512426 . Registered on 9 October 2007. ClinicalTrials.gov, NCT01503827 . Registered on 4 January 2012. Trial group reference numbers ANZMTG 01.07, TROG 08.05.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Lo SN, Hong AM, Haydu LE, et al. Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan. Trials. 2019. PMID: 31382986. doi:10.1186/s13063-019-3555-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。